Spur Therapeutics Limited
Research and experimental development on biotechnology · Stevenage
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
09500073- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-03-19
- Jurisdiction
- —
- Registered office
- 1SYCAMORE HOUSE, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, SG1 2BP, ENGLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsUniversity of Leeds and Freeline Therapeutics LimitedInnovate UK · Knowledge Transfer Partnership · 2020-02-01 – 2023-08-31 · with 1 other participant
University of Leeds and Freeline Therapeutics Limited
Innovate UK · Knowledge Transfer Partnership · 2020-02-01 – 2023-08-31 · with 1 other participant
Freeline Therapeutics Limited—
Using adeno-associated virus gene therapy to treat rare kidney diseaseLead
Innovate UK · Collaborative R&D · 2019-02-01 – 2022-03-31
£938,666
awarded
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical TrialsLeadInnovate UK · Collaborative R&D · 2018-11-01 – 2021-10-31 · with 2 other participants£297,645awarded
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical TrialsLead
Innovate UK · Collaborative R&D · 2018-11-01 – 2021-10-31 · with 2 other participants
£297,645
awarded
Cell Therapy Catapult Limited£398,457
Freeline Therapeutics Limitedlead£297,645
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapiesInnovate UK · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants£234,243awarded
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapies
Innovate UK · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants
£234,243
awarded
Freeline Therapeutics Limited£234,243
NHS Blood and Transplant£221,652
Establishing Freeline Commercial Scale Viral Gene Therapy Manufacture for Fabry DiseaseLeadInnovate UK · Collaborative R&D · 2017-12-01 – 2020-01-31 · with 1 other participant£979,886awarded
Establishing Freeline Commercial Scale Viral Gene Therapy Manufacture for Fabry DiseaseLead
Innovate UK · Collaborative R&D · 2017-12-01 – 2020-01-31 · with 1 other participant
£979,886
awarded
Freeline Therapeutics Limitedlead£979,886
Cell Therapy Catapult Limited£600,012